TeselaGen
San Francisco
About TeselaGen
TeselaGen Biotechnology develops DNA design and assembly tools for biology. It offers a cloud based solution for combinatorial gene design and editing. Its solutions include Graphical Sequence Editor to visualize, edit, and annotate gene and plasmid libraries; Symbolic CAD/CAM to piece together novel constructs using parts from its database; Fabrication Intelligence to generate protocols that are optimized for cost, and verified to assemble quickly and accurately; and Validation to align sequence traces with design variants. Michael Fero, Eduardo Abeliuk, and Nathan Hillson founded TeselaGen on June 1, 2011. It has its headquarters in San Francisco in California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $4.8M
- Last round: Non-Equity Assistance (Aug 2023)
- Website: teselagen.com
- Phone: 650-387-5932
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Information Technology, Life Science
Social Profiles
Canonical: https://fsome.com/organization/teselagen-19679 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.